Epilepsy and pregnancy

Seizure

Volumn 11, Issue SUPPL. A, 2002, Pages 212-219

  Crawford, Pamela ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; VITAMIN K GROUP;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT THERAPY; APGAR SCORE; ARTICLE; BREAST MILK; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EXCRETION; DRUG MILK LEVEL; DRUG MONITORING; DRUG URINE LEVEL; ECLAMPSIA; EPILEPSY; FEEDING DISORDER; FETUS RISK; HIGH RISK PREGNANCY; HUMAN; HYPEREMESIS GRAVIDARUM; IRRITABILITY; LETHARGY; LOW BIRTH WEIGHT; NEWBORN DEATH; NEWBORN HEMORRHAGIC DISEASE; NONHUMAN; PERINATAL DEATH; POSTNATAL DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; STILLBIRTH; TERATOGENICITY; VAGINA BLEEDING; BLOOD; DRUG EFFECT; FEMALE; FETUS DISEASE; PRENATAL CARE; PRENATAL DEVELOPMENT; REVIEW;

ANTICONVULSANTS; EMBRYO AND FETAL DEVELOPMENT; EPILEPSY; FEMALE; FETAL DISEASES; FOLIC ACID; HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; VALPROIC ACID; VITAMIN K; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS;

EID: 0036014469     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Pregnancy and teratogenesis
2. Proactive pre-conception counselling for women with epilepsy-is it effective?
3. Risk factors for the increased seizure frequency during pregnancy and puerperium
4. Pharmacokinetics of antiepileptic drugs in pregnant women
5. Plasma antiepileptic drug concentrations during pregnancy
6. Antiepileptic drug disposition during pregnancy
7. Epilepsy and pregnancy: A study of 153 pregnancies in 59 patients
8. Pregnancy complications and outcomes in a cohort of women with epilepsy
9. Effect of maternal seizures on the fetus
10. Minor anomalies in offspring of epileptic mothers
11. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: A multicentre prospective study
12. Fetal malformations associated with maternal hypoxia
13. Epilepsy in pregnancy
14. Epilepsy and pregnancy. A prospective study of 154 pregnancies in epileptic women
15. Obstetric outcome in women with epilepsy
16. Problems and management of the pregnant women with epilepsy
17. Status epilepticus during labour. A case report
18. The management of pregnancy in women with epilepsy
19. Multi-institutional study on the teratogenicity and foetal toxicity of anticonvulsants: A report of a collaborative study group in Japan
20. The epileptic mother and her child
21. Teratogenicity of anticonvulsant drugs !: Review of the literature
22. The teratogenic effects of epilepsy and anticonvulsant drugs
23. Fetal development and sensitivity periods in man
24. The fetal hydantoin syndrome
25. Anticonvulsant drugs and malformations: Is there drug specificity?
26. Cardiac defects in children of mothers receiving anticonvulsant therapy during pregnancy
27. Congenital malformations and seizure disorders in the offspring of parental epilepsy
28. Maternal epilepsy and congenital malformations: Correlation with maternal plasma anticonvulsant levels during pregnancy
29. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy parallel by change in pattern of malformations
30. Teratogenic and pharmacokinetics studies of primidone during pregnancy and in the offspring of epileptic women
31. Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero
32. Anticonvulsant drugs in monotherapy. Effect on the fetus
33. Fetal head growth retardation associated with antiepileptic drugs
34. Malformations and minor anomalies in the children epileptic mothers: Preliminary results of the prospect of Helsinki study
35. Outcome of pregnancy in women with epilepsy
36. Possible teratogenicity of valproic acid
37. In utero exposure to valproate and neural tube defects
38. Maternal valproic acid and congenital neural tube defects
39. Sodium valproate and neural tube defects
40. Major malformations and minor anomalies in infants born to women receiving valproic acid
41. Spectrum of neural tube defects in 34 prenatally exposed to antiepileptic drugs
42. The UK epilepsy and pregnancy register
43. Towards the mechanism valproic acid induced neural tube defects
44. Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy
45. Major malformations associated with maternal use of antiepileptic drugs
46. Epilepsy and pregnancy: A report from the Oxford Record Linkage Study
47. Genetic aspects of malformations
48. Intelligence of children of epileptic mothers
49. Minor anomalies and effects on psychomotor development associated with maternal use of antiepileptic drugs
50. Additional educational needs in children born to mothers with epilepsy
51. Patterns of malformations in the children of women treated with carbamazepine during pregnancy
52. Complications of pregnancy, labour and delivery in epileptic women
53. Epilepsy, antiepileptic drugs, and the risk of spontaneous abortion
54. The course and outcome of pregnancy in women with epilepsy
55. Pregnancy complications and outcomes in a cohort of women with epilepsy
56. Outcome of pregnancy in women with epilepsy-Norway 1967 to 1968
57. Complications during pregnancy and delivery
58. Epilepsy, pregnancy, and major birth anomalies: An Italian prospective, controlled study
59. Fetal growth in the offspring of epileptic women: Results in Italian multicentric cohort study
60. Pregnancy, epilepsy, management in outcome: A 10 year prospective study
61. The course and outcome of pregnancy in women with epilepsy-a six-year prospective study
62. Neonatal outcome in infants of epileptic mothers
63. Insidious effect of antiepileptic drugs in the perinatal period
64. Evaluation of placental morphology and growth factor receptors in women receiving antiepileptic drugs: A pilot
65. Foetal heart rates during a maternal grand mal epileptic seizure
66. Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between breast differences in two patients
67. Factors affecting the milk to plasma drug concentration ratio in lactating women: Physical interactions with protein and fat
68. Anticonvulsants during pregnancy and lactation transplacental, maternal and neonatal pharmacokinetics
69. Breast feeding and antiepileptic drugs
70. Lamotrigine in pregnancy and lactation
71. How much risk does a women with active epilepsy pose to her newborn child in the puerperium
72. Best practice guidelines for the management of women with epilepsy